These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38014309)

  • 1. Unraveling activation-related rearrangements and intrinsic divergence from ligand-induced conformational changes of the dopamine D3 and D2 receptors.
    Lee KH; Shi L
    bioRxiv; 2023 Nov; ():. PubMed ID: 38014309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unraveling Activation-Related Rearrangements and Intrinsic Divergence from Ligand-Specific Conformational Changes of the Dopamine D3 and D2 Receptors.
    Lee KH; Shi L
    J Chem Inf Model; 2024 Mar; 64(6):1778-1793. PubMed ID: 38454785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single glycine in extracellular loop 1 is the critical determinant for pharmacological specificity of dopamine D2 and D3 receptors.
    Michino M; Donthamsetti P; Beuming T; Banala A; Duan L; Roux T; Han Y; Trinquet E; Newman AH; Javitch JA; Shi L
    Mol Pharmacol; 2013 Dec; 84(6):854-64. PubMed ID: 24061855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel "Activation Switch" Motif Common to All Aminergic Receptors.
    Lee KH; Manning JJ; Javitch J; Shi L
    J Chem Inf Model; 2023 Aug; 63(16):5001-5017. PubMed ID: 37540602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors Governing Selectivity of Dopamine Receptor Binding Compounds for D2R and D3R Subtypes.
    Hayatshahi HS; Luedtke RR; Taylor M; Chen PJ; Blass BE; Liu J
    J Chem Inf Model; 2021 Jun; 61(6):2829-2843. PubMed ID: 33988991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leveraging a Low-Affinity Diazaspiro Orthosteric Fragment to Reduce Dopamine D
    Reilly SW; Riad AA; Hsieh CJ; Sahlholm K; Jacome DA; Griffin S; Taylor M; Weng CC; Xu K; Kirschner N; Luedtke RR; Parry C; Malhotra S; Karanicolas J; Mach RH
    J Med Chem; 2019 May; 62(10):5132-5147. PubMed ID: 31021617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons.
    Bono F; Savoia P; Guglielmi A; Gennarelli M; Piovani G; Sigala S; Leo D; Espinoza S; Gainetdinov RR; Devoto P; Spano P; Missale C; Fiorentini C
    Mol Neurobiol; 2018 Feb; 55(2):1054-1067. PubMed ID: 28092083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor.
    Adhikari P; Xie B; Semeano A; Bonifazi A; Battiti FO; Newman AH; Yano H; Shi L
    Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33924613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selectivity and activation of dopamine D3R from molecular dynamics.
    Feng Z; Hou T; Li Y
    J Mol Model; 2012 Dec; 18(12):5051-63. PubMed ID: 22752545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and evaluation of bitopic arylpiperazinephenyl-1,2,4-oxadiazoles as preferential dopamine D3 receptor ligands.
    Cao Y; Min C; Acharya S; Kim KM; Cheon SH
    Bioorg Med Chem; 2016 Jan; 24(2):191-200. PubMed ID: 26707842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current drug treatments targeting dopamine D3 receptor.
    Leggio GM; Bucolo C; Platania CB; Salomone S; Drago F
    Pharmacol Ther; 2016 Sep; 165():164-77. PubMed ID: 27343365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RalA employs GRK2 and β-arrestins for the filamin A-mediated regulation of trafficking and signaling of dopamine D2 and D3 receptor.
    Zheng M; Zhang X; Sun N; Min C; Zhang X; Kim KM
    Biochim Biophys Acta; 2016 Aug; 1863(8):2072-83. PubMed ID: 27188791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palmitoylation on the carboxyl terminus tail is required for the selective regulation of dopamine D2 versus D3 receptors.
    Zhang X; Le HT; Zhang X; Zheng M; Choi BG; Kim KM
    Biochim Biophys Acta; 2016 Sep; 1858(9):2152-2162. PubMed ID: 27349735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The E2.65A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors.
    Verma RK; Abramyan AM; Michino M; Free RB; Sibley DR; Javitch JA; Lane JR; Shi L
    PLoS Comput Biol; 2018 Jan; 14(1):e1005948. PubMed ID: 29337986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of bitopic ligands based on fallypride and evaluation of their affinity and selectivity towards dopamine D
    Tian GL; Hsieh CJ; Taylor M; Lee JY; Riad AA; Luedtke RR; Mach RH
    Eur J Med Chem; 2023 Dec; 261():115751. PubMed ID: 37688938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRs.
    Ferruz N; Doerr S; Vanase-Frawley MA; Zou Y; Chen X; Marr ES; Nelson RT; Kormos BL; Wager TT; Hou X; Villalobos A; Sciabola S; De Fabritiis G
    Sci Rep; 2018 Jan; 8(1):897. PubMed ID: 29343833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Analogues of (R)-5-(Methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one (Sumanirole) Provide Clues to Dopamine D2/D3 Receptor Agonist Selectivity.
    Zou MF; Keck TM; Kumar V; Donthamsetti P; Michino M; Burzynski C; Schweppe C; Bonifazi A; Free RB; Sibley DR; Janowsky A; Shi L; Javitch JA; Newman AH
    J Med Chem; 2016 Apr; 59(7):2973-88. PubMed ID: 27035329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of dopamine D2 and D3 receptors in the human retina revealed by positron emission tomography and targeted mass spectrometry.
    Caravaggio F; Scifo E; Sibille EL; Hernandez-Da Mota SE; Gerretsen P; Remington G; Graff-Guerrero A
    Exp Eye Res; 2018 Oct; 175():32-41. PubMed ID: 29883636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional and source-based patterns of [
    Worhunsky PD; Matuskey D; Gallezot JD; Gaiser EC; Nabulsi N; Angarita GA; Calhoun VD; Malison RT; Potenza MN; Carson RE
    Neuroimage; 2017 Mar; 148():343-351. PubMed ID: 28110088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unveiling the Differences in Signaling and Regulatory Mechanisms between Dopamine D
    Kim KM
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.